Neutropenia – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033


 Neutrophils play a crucial role in the immune system by ingesting, destroying, and digesting invading microorganisms, encompassing fungi and bacteria. Failure to fulfill this role results in immunodeficiency, characterized primarily by recurrent infections. A standard circulating neutrophil count is above 1.5 x 10/L. Neutropenia, defined as an absolute neutrophil count (ANC) below 1500 per microliter (1500/microL), can be categorized as asymptomatic (mild), moderate, or severe, indicating the risk of infection. The severity of neutropenia is stratified as follows:

·       Mild: 1000 to 1500/mcL (1 to 1.5 × 10^9/L)

·       Moderate: 500 to 1000/mcL (0.5 to 1 × 10^9/L)

·       Severe: < 500/mcL (< 0.5 × 10^9/L)

Primary defects in neutrophil function involve failures in adhering to endothelial cells, abnormal chemotaxis, inadequate bacterial ingestion and killing, insufficient production of microbicidal compounds, defective formation of phagolysosomes, and diminished synthesis of toxic reactive oxygen species. Common infections in individuals with profound neutropenia include cellulitis, furunculosis, pneumonia, sepsis, and sinusitis. Neutropenia is typically asymptomatic until an infection arises, with fever being a standard indicator. Severe neutropenia may obscure typical signs of inflammation, and focal symptoms, such as oral ulcers, can be subtle. Drug-induced neutropenia may present with fever, rash, and lymphadenopathy due to hypersensitivity reactions. Neutropenia can be distinguished from antibody deficiency disorders, where immunoglobulin levels are below normal or absent, leading to recurrent bacterial and fungal infections. The complement system deficiency, like C3 deficiency, can mimic neutropenia but can be differentiated through quantification and functional assessment. The prognosis in neutropenia disorders varies based on the cause and affected organs. Chronic Granulomatous Disease (CGD) has a better prognosis with successful allogeneic bone marrow transplantation. Neutropenia induced by chemotherapy or drugs may be remitted after treatment cessation. Some primary neutrophil function defects can lead to fatal diseases and premature death.

·       The estimated prevalence of neutropenia is 1.24%, corresponding to approximately 35.5 million individuals in the United States.

 

Thelansis’s “Neutropenia Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential Neutropenia treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China).

 

KOLs insights of Neutropenia across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs.

Neutropenia Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model, Market uptake and patient share uptake, Attribute Analysis, Analog Analysis, Disease burden, and pricing scenario, Summary, and Insights.

Thelansis Competitive Intelligence (CI) practice has been established based on a deep understanding of the pharma/biotech business environment to provide an optimized support system to all levels of the decision-making process. It enables business leaders in forward-thinking and proactive decision-making. Thelansis supports scientific and commercial teams in seamless CI support by creating an AI/ ML-based technology-driven platform that manages the data flow from primary and secondary sources.

Read more: Neutropenia – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Tags: Neutropenia, Neutropenia market outlook, Neutropenia competitive landscape, Neutropenia market forecast, Thelansis, Primary market research, KOL insights, Competitive Intelligence (CI)

Comments

Post a Comment

Popular posts from this blog

Acne Vulgaris – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2022 To 2032

Image
  Acne vulgaris, a prevalent pilosebaceous unit inflammatory skin disorder, follows a persistent course. Typically presenting as papules, pustules, or nodules, it primarily occurs on the face but can also impact the upper arms, trunk, and back. The development of acne results from the sebaceous glands' heightened sensitivity to normal androgen levels, aggravated by Cutibacterium acnes (formerly known as Propionibacterium acnes), a bacterial species that triggers inflammation. The pathogenesis of acne vulgaris involves a complex interplay of factors such as the activation of sebaceous glands by androgens, imbalances in the pilosebaceous follicle microbiome, and cellular immune responses. Genetic predisposition and dietary influences also contribute to the condition's onset and progression. The initial stage is the micro-comedo, a small plug primarily composed of corneocytes in the lower follicular infundibulum. Microcomedones evolve into various acne lesions, including closed co...
Read more

Herpes Simplex Virus (HSV) – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
 Herpes simplex virus (HSV) causes an infection that affects the external genitalia, anal region, mucosal surfaces, and skin in other body parts. Herpes simplex virus is a ubiquitous, host-adapted pathogen that causes various disease states. There are two types of HSV with two distinct DNA viruses, type 1 (HSV-1) and type 2 (HSV-2). Both the types are closely related but differ epidemiologically. HSV-1 is traditionally associated with orofacial disease by affecting the mouth and lips with fever blisters and cold sores, whereas HSV-2 is associated traditionally with genital disease infecting genitals and rectum area with sores and is classified as STD (sexually transmitted disease). As HSV-1 is associated with genital infections more often than HSV-2, lesion location is not necessarily of viral type. HSV can spread through direct contact. Almost 80% of Herpes simplex infections are asymptomatic, while symptomatic infections can be characterized by significant morbidity and recurrenc...
Read more

HR+/HER2- Breast Cancer – Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033

Image
Thelansis’s “HR+/HER2- Breast Cancer Market Outlook, Epidemiology, Competitive Landscape, and Market Forecast Report – 2023 To 2033" covers disease overview, epidemiology, drug utilization, prescription share analysis, competitive landscape, clinical practice, regulatory landscape, patient share, market uptake, market forecast, and key market insights under the potential HR+/HER2- Breast Cancer treatment modalities options for eight major markets (USA, Germany, France, Italy, Spain, UK, Japan, and China). KOLs insights of HR+/HER2- Breast Cancer across 8 MM market from the centre of Excellence/ Public/ Private hospitals participated in the study. Insights around current treatment landscape, epidemiology, clinical characteristics, future treatment paradigm, and Unmet needs. HR+/HER2- Breast Cancer Market Forecast Patient Based Forecast Model (MS. Excel Based Automated Dashboard), which Data Inputs with sourcing, Market Event, and Product Event, Country specific Forecast Model,...
Read more